CervoMed CRVO
NASDAQ CRVO
$1.80 +0.43 (+31.66%)
As of: Nov 11, 2026 · 12:50 PM EST

CervoMed (CRVO) Long-Term Debt Issuances (2012 - 2016)

Updated

CervoMed's Long-Term Debt Issuances came in at $1.88 million for FY2016, down 21.7% from $2.4 million in FY2015.

Analysis

CervoMed (CRVO) Long-Term Debt Issuances (2012 - 2016) Analysis & Trends

Going back to FY2010, CervoMed's Long-Term Debt Issuances data covers 7 years.

  • Long-Term Debt Issuances carries a five-year compound annual growth rate of 37.1% (FY2011 to FY2016).
  • The five-year range for annual Long-Term Debt Issuances is $400,000 (FY2014) to $3.48 million (FY2012).
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $2.4 million in FY2015 (+500.4%), $400,000 in FY2014 (-42.9%), $700,000 in FY2013 (-79.9%) and $3.48 million in FY2012 (+797.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 CervoMed 20.73 Mn -57.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 -291,185.00
Mar 31, 2014 400,000.00
Sep 30, 2013 500,000.00
Mar 31, 2013 200,000.00
Dec 31, 2012 611,787.00
Sep 30, 2012 673,317.00
Jun 30, 2012 366,027.00
Mar 31, 2012 1.83 Mn
API Access

CervoMed Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=CRVO&period=max&api_key=YOUR_API_KEY